• 24260 Citations
  • 83 Scopus h-Index
1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Letter
2020

The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias

Baughn, L. B., Li, Z., Pearce, K., Vachon, C. M., Polley, M. Y., Keats, J., Elhaik, E., Baird, M., Therneau, T., Cerhan, J. R., Bergsagel, P. L., Dispenzieri, A., Rajkumar, S. V., Asmann, Y. W. & Kumar, S., Mar 1 2020, In : Blood cancer journal. 10, 3, 39.

Research output: Contribution to journalLetter

Open Access
2019

MYC dysregulation in the progression of multiple myeloma

MMRF CoMMpass Network, Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

2 Scopus citations
2017

Systolic dysfunction associated with carfilzomib use in patients with multiple myeloma

Jain, T., Narayanasamy, H., Mikhael, J. R., Reeder, C. B., Bergsagel, P. L., Mayo, A., Stewart, A. K., Mookadam, F. & Fonseca, R., Dec 1 2017, In : Blood Cancer Journal. 7, 12, 642.

Research output: Contribution to journalLetter

2 Scopus citations
2016

Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma

Jain, T., Dueck, A., Kosiorek, H. E., Ginos, B. F., Mayo, A., Reeder, C. B., Chesi, M., Mikhael, J. R., Stewart, A. K., Bergsagel, P. L. & Fonseca, R., Dec 1 2016, In : American Journal of Hematology. 91, 12, p. E504-E505

Research output: Contribution to journalLetter

2 Scopus citations
2014

Long-term follow-up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia

Chen, C. I., Paul, H., Wang, T., Le, L. W., Dave, N., Kukreti, V., Nong Wei, E., Lau, A., Bergsagel, P. L. & Trudel, S., Jun 2014, In : British journal of haematology. 165, 5, p. 731-733 3 p.

Research output: Contribution to journalLetter

16 Scopus citations

Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma

Reeder, C. B., Reece, D. E., Kukreti, V., Mikhael, J. R., Chen, C., Trudel, S., Laumann, K., Vohra, H., Fonseca, R., Bergsagel, P. L., Leis, J. F., Tiedemann, R. & Stewart, A. K., Nov 1 2014, In : British journal of haematology. 167, 4, p. 563-565 3 p.

Research output: Contribution to journalLetter

30 Scopus citations
2013

Degree of focal immunoglobulin heavy chain locus deletion as a measure of B-cell tumor purity

Bergsagel, P. L. & Kuehl, W. M., Oct 1 2013, In : Leukemia. 27, 10, p. 2067-2111 45 p.

Research output: Contribution to journalLetter

3 Scopus citations
2010

Once- versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma

Reeder, C. B., Reece, D. E., Kukreti, V., Chen, C., Trudel, S., Laumann, K., Hentz, J., Pirooz, N. A., Piza, J. G., Tiedemann, R., Mikhael, J. R., Bergsagel, P. L., Leis, J. F., Fonseca, R. & Stewart, A. K., Apr 22 2010, In : Blood. 115, 16, p. 3416-3417 2 p.

Research output: Contribution to journalLetter

142 Scopus citations
2009

Reply to the research mission in myeloma by Richardson et al

Bergsagel, P. L., Jan 1 2009, In : Leukemia. 23, 2, p. 423-424 2 p.

Research output: Contribution to journalLetter

2008

Translocation t(4;14) retains prognostic significance even in the setting of high-risk molecular signature [16]

Chng, W. J., Kuehl, W. M., Bergsagel, P. L. & Fonseca, R., Feb 2008, In : Leukemia. 22, 2, p. 459-461 3 p.

Research output: Contribution to journalLetter

25 Scopus citations

WSU-WM and BCWM.1 should not be assumed to represent Waldenström macroglobulinemia cell lines

Bergsagel, P. L. & Kuehl, W. M., Aug 1 2008, In : Blood. 112, 3, 1 p.

Research output: Contribution to journalLetter

6 Scopus citations
2007

Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution [4]

Stewart, A. K., Chang, H., Trudel, S., Anderson, K. C., Richardson, P., Alsina, M., Reece, D., Young, S., Sable-Hunt, A., Li, Z., Keats, J., Van Wier, S., Ahmann, G., Price-Troska, T., Giusti, K., Bergsagel, P. L., Chesi, M. & Fonseca, R., Nov 2007, In : Leukemia. 21, 11, p. 2358-2359 2 p.

Research output: Contribution to journalLetter

18 Scopus citations

Expression and mutation status of candidate kinases in multiple myeloma [13]

Claudio, J. O., Zhan, F., Zhuang, L., Khaja, R., Zhu, Y. X., Sivananthan, K., Trudel, S., Masih-Khan, E., Fonseca, R., Bergsagel, P. L., Scherer, S. W., Shaughnessy, J. & Stewart, A. K., May 2007, In : Leukemia. 21, 5, p. 1124-1127 4 p.

Research output: Contribution to journalLetter

14 Scopus citations

Survival of genetic subtypes of relapsed myeloma may be modulated by secondary events [5]

Chng, W. J., Mulligan, G., Bryant, B. & Bergsagel, L., Apr 15 2007, In : Blood. 109, 8, p. 3610-3611 2 p.

Research output: Contribution to journalLetter

8 Scopus citations
2005

Maintained rules of development in a mouse B-cell tumor [7]

Robbiani, D. F., Colon, K., Affer, M., Chesi, M. & Bergsagel, P. L., Jul 2005, In : Leukemia. 19, 7, p. 1278-1280 3 p.

Research output: Contribution to journalLetter

3 Scopus citations
2004

Bone lesions in molecular subtypes of multiple myeloma [7]

Robbiani, D. F., Chesi, M. & Bergsagel, P. L., Jul 8 2004, In : New England Journal of Medicine. 351, 2, p. 197-198 2 p.

Research output: Contribution to journalLetter

32 Scopus citations
1984

Psychosocial Status in Chronic Illness

Bergsagel, P. L., Finucane, T. E., Meenan, R. F., Mason, J. H., Kazis, L. E., Hürny, C., Holland, J. C., Barofsky, I., Bloom, J. R., Cassileth, B. R., Lusk, E. J., Strouse, T. B., Miller, D. S., Brown, L. L., Cross, P. A. & Tenagila, A. N., Dec 13 1984, In : New England Journal of Medicine. 311, 24, p. 1580-1582 3 p.

Research output: Contribution to journalLetter